Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corteva (CTVA) Receivables (2018 - 2025)

Corteva has reported Receivables over the past 8 years, most recently at $6.4 billion for Q4 2025.

  • For Q4 2025, Receivables fell 5.43% year-over-year to $6.4 billion; the TTM value through Dec 2025 reached $6.4 billion, down 5.43%, while the annual FY2025 figure was $6.4 billion, 5.43% down from the prior year.
  • Receivables for Q4 2025 was $6.4 billion at Corteva, down from $9.1 billion in the prior quarter.
  • Over five years, Receivables peaked at $10.0 billion in Q2 2025 and troughed at $5.7 billion in Q4 2022.
  • A 5-year average of $7.6 billion and a median of $7.7 billion in 2024 define the central range for Receivables.
  • Biggest five-year swings in Receivables: soared 63.32% in 2021 and later decreased 8.89% in 2024.
  • Year by year, Receivables stood at $6.1 billion in 2021, then fell by 5.94% to $5.7 billion in 2022, then grew by 16.59% to $6.6 billion in 2023, then grew by 1.35% to $6.7 billion in 2024, then decreased by 5.43% to $6.4 billion in 2025.
  • Business Quant data shows Receivables for CTVA at $6.4 billion in Q4 2025, $9.1 billion in Q3 2025, and $10.0 billion in Q2 2025.